ArticleOncotarget2017

Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.

Elodie Jobard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.